Abstract
This study investigates the molecular basis of a male patient presenting with aplastic anemia (AA) and related symptoms of macrocytosis and mild thrombocytopenia. In addition, this patient also presents symptoms not usually found in AA patients, such as fatty liver, liver cirrhosis with portal hypertension, diffuse cerebral and cerebellar atrophy, and congenital left sensorineural hearing loss. As such, it is hypothesized that the patient has AA that is secondary to inherited bone marrow failure syndromes related to telomere biology disorders. Thus, to identify the underlying genetic cause of the disease, relative telomere length (RTL) of proband and family members was determined by qPCR, followed by identification of disease-causing variants through next-generation sequencing of the proband. The proband has a RTL of 0.11 (− 5.96 SD) which is shorter than the 1st percentile (− 2.33 SD). As RTL analysis indicates significant telomere shortening in the patient, it is likely that the patient has a telomere biology disorder. 8 variants in genes (DKC1, ATXN3, PTPRQ, ABCB4, DIAPH3, TBP, PARP1) associated with our patient’s phenotype, 2 of which were previously reported and were also shortlisted as potential candidates. However, upon curation, these variants were found to be of uncertain significance, and the genetic cause of our patient’s condition remains elusive. Nonetheless, we were able to confirm that the patient had significant shortening of telomeres.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schoettler, M. L., & Nathan, D. G. (2018). The pathophysiology of acquired aplastic anemia. Hematology Oncology Clinics of North America, 32(4), 581–594.
Moore, C. A., & Krishnan, K. (2020). Aplastic anemia (updated 2020 Nov 23). In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
Vaht, K., Göransson, M., Carlson, K., Isaksson, C., Lenhoff, S., Sandstedt, A., et al. (2017). Incidence and outcome of acquired aplastic anemia: Real-world data from patients diagnosed in Sweden from 2000 to 2011. Haematologica, 102(10), 1683–1690.
Alzahrani, N., Ashor, N., Fathi, T., Bukhari, D., & Zaher, G. (2018). Idiopathic severe aplastic anemia with a delayed response to immunosuppressive therapy: A case report. Clinical Case Reports, 6(6), 1029–1032.
Calado, R. T., Regal, J. A., Kleiner, D. E., Schrump, D. S., Peterson, N. R., & Pons, V. et al. (2009). A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One, 4(11), e7926.
Gitto, L., Stoppacher, R., Richardson, T. E., & Serinelli, S. (2020). DC. Autopsy and Case Reports, 10(3).
Savage, S., & Bertuch, A. (2010). The genetics and clinical manifestations of telomere biology disorders. Genetics in Medicine, 12, 753–764.
Ball, S. E., Gibson, F. M., Rizzo, S., Tooze, J. A., Marsh, J. C., & Gordon-Smith, E. C. (1998). Progressive telomere shortening in aplastic anemia. Blood, 91(10), 3582–3592.
Gramatges, M. M., & Bertuch, A. A. (2013). Short telomeres: From dyskeratosis congenita to sporadic aplastic anemia and malignancy. Translational Research: The Journal of Laboratory and Clinical Medicine, 162(6).
Acquired Aplastic Anemia (n.d.). NORD (National Organization for Rare Disorders).
Hartung, H. D., Olson, T. S., & Bessler, M. (2013). Acquired aplastic anemia in children. Pediatric Clinics of North America, 60(6), 1311–1336.
Moore, C. A., & Krishnan, K. (2020). Bone marrow failure (updated 2020 Jul 13). In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
Balogh, E. P., Miller, B. T., & Ball, J. R., Committee on Diagnostic Error in Health Care; Board on Health Care Services & The National Academies of Sciences (2015). The diagnostic process. National Academies Press (US). www.ncbi.nlm.nih.gov
Fernández García, M. S., & Teruya-Feldstein, J. (2014). The diagnosis and treatment of dyskeratosis congenita: A review. Journal of Blood Medicine, 5, 157–167.
Nelson, A., Myers, K. (2021). Shwachman-diamond syndrome. 2008 Jul 17 (updated 2018 Oct 18). In M. P. Adam, H. H. Ardinger, R. A. Pagon, et al. (Eds.), GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle (1993–2021)
Joglekar, M. V., Satoor, S. N., Wong, W. K. M., Cheng, F., Ma, R. C. W., & Hardikar, A. A. (2020). An optimised step-by-step protocol for measuring relative telomere length. Methods and Protocols, 3(2), 27.
Cawthon, R. M. (2002). Telomere measurement by quantitative PCR. Nucleic Acids Research, 30(10), e47.
Alter, B. P., Rosenberg, P. S., Giri, N., Baerlocher, G. M., Lansdorp, P. M., & Savage, S. A. (2012). Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica, 97(3), 353–359.
Arias-Salgado, E. G., Galvez, E., Planas-Cerezales, L., Pintado-Berninches, L., Vallespin, E., Martinez, P., et al. (2019). Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes. Orphanet Journal of Rare Diseases, 14.
Savage, S. A. (2019, November 21). Dyskeratosis congenita. Seattle: Nih.Gov; University of Washington.
Rizvi, S., Raza, S. T., & Mahdi, F. (2015). Telomere length variations in aging and age-related diseases. Current Aging Science, 7(3), 161–167.
Shammas, M. A. (2011). Telomeres, lifestyle, cancer, and aging. Current Opinion in Clinical Nutrition and Metabolic Care, 14(1), 28–34.
Starkweather, A. R., Alhaeeri, A., Montpetit, A., Brumelle, J., Filler, K., Montpetit, M., Mohanraj, L., Lyon, D. E., & Jackson-Cook, C. K. (2014). An integrative review of factors associated with telomere length and implications for biobehavioral research. Nursing Research, 63(1), 36–50.
Anna, A., & Monika, G. (2018). Splicing mutations in human genetic disorders: Examples, detection, and confirmation. Journal of Applied Genetics, 59(3), 253–268.
OMIM Entry—*300126—DYSKERIN; DKC1 (n.d.).
Chalkoo, A. H., Kaul, V., & Wani, L. A. (2014). Zinsser-Cole-Engmann syndrome: A rare case report with literature review. Journal of Clinical and Experimental Dentistry, 6(3), e303–e306.
OMIM Entry—# 305000—DYSKERATOSIS CONGENITA, X-LINKED; DKCX (n.d.).
National Organization for Rare Disorders (2020). Dyskeratosis congenita.
OMIM Entry—*607047—ATAXIN 3; ATXN3 (n.d.).
OMIM Entry—*171060—ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 4; ABCB4 (n.d.).
OMIM Entry—*603317—PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, Q; PTPRQ (n.d.).
OMIM Entry—*614567—DIAPHANOUS-RELATED FORMIN 3; DIAPH3 (n.d.).
OMIM Entry—*600075—TATA BOX-BINDING PROTEIN; TBP (n.d.).
Ramirez, M. H., Adelfalk, C., Kontou, M., Hirsch-Kauffmann, M., & Schweiger, M. (2003). The cellular control enzyme PolyADP Ribosyl Transferase is eliminated in cultured fanconi anemia fibroblasts at confluency. Biological Chemistry, 384(1), 169–174.
ATXN3 [Internet], Bethesda: National Library of Medicine (US), National Center for Biotechnology Information (2004)
Bettencourt, C., & Lima, M. (2011). Machado-Joseph disease: From first descriptions to new perspectives. Orphanet Journal of Rare Diseases, 6(1), 35.
Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., et al. (1994). CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genetics, 8(3), 221–228.
Stochmanski, S. J., Therrien, M., Laganière, J., Rochefort, D., Laurent, S., Karemera, L., et al. (2012). Expanded ATXN3 frameshifting events are toxic in Drosophila and mammalian neuron models. Human Molecular Genetics, 21(10), 2211–2218.
Stättermayer, A. F., Halilbasic, E., Wrba, F., Ferenci, P., & Trauner, M. (2020). Variants in ABCB4 across the spectrum of cholestatic liver diseases in adults. Journal of Hepatology.
Davit-Spraul, A., Gonzales, E., Baussan, C., & Jacquemin, E. (2010). The spectrum of liver diseases related to ABCB4 gene mutations: Pathophysiology and clinical aspects. Seminars in Liver Disease, 30(02), 134–146.
Vollrath, M. A., Kwan, K. Y., & Corey, D. P. (2007). The micromachinery of mechanotransduction in hair cells. Annual Review of Neuroscience, 30(1), 339–365.
Wu, X., Wang, S., Chen, S., Wen, Y., Liu, B., Xie, W., et al. (2018). Autosomal recessive congenital sensorineural hearing loss due to a novel compound heterozygous PTPRQ mutation in a Chinese family. Neural Plasticity, 2018, 1–6.
Montpetit, A. J., Alhareeri, A. A., Montpetit, M., Starkweather, A. R., Elmore, L. W., Filler, K., et al. (2014). Telomere length: a review of methods for measurement. Nursing Research, 63(4), 289–299.
Ratnasamy, V., Navaneethakrishnan, S., Sirisena, N., et al. (2018). Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: A case report. BMC Medical Genetics, 19, 85 (2018).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Tong, B.L.Y. et al. (2022). Investigating the Genetic Etiology of Disease in a Patient with Aplastic Anemia. In: Guo, H., Ren, H., Wang, V., Chekole, E.G., Lakshmanan, U. (eds) IRC-SET 2021. Springer, Singapore. https://doi.org/10.1007/978-981-16-9869-9_4
Download citation
DOI: https://doi.org/10.1007/978-981-16-9869-9_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-9868-2
Online ISBN: 978-981-16-9869-9
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)